Updated:
Huajun Pharmaceutical Group
Huajun Pharmaceutical Group is a corporate investor based in Yingkou; the Altss profile covers its classification, headquarters, registration, AUM band, and...
Huajun Pharmaceutical Group
Huajun Pharmaceutical Group is a corporate investor based in Yingkou, China. It invests in two funds. Its regional focus is Asia.
General information
Firm type
Corporate Investor
Location
Region
Asia
Country
China
City
Yingkou
Corporate office
Yingkou, Liaoning, China
Principals
Meng Guangbao
Founder and Executive Chairman
Wu Jiahui
Executive Director, China Huajun Group Limited
Sector focus
Frequently asked questions
Does the group invest only in pharmaceuticals?
No. Despite the pharmaceutical name, the parent Huajun Group holds a diversified asset base that includes commercial real estate in Yingkou, Dalian, and Shanghai, a hot spring resort hotel, and an art collection. Investment activity spans beyond life sciences, though pharmaceutical manufacturing remains the core industrial anchor in the Yingkou industrial park.
What is the relationship between Huajun Pharmaceutical Group and China Huajun Group Limited?
Huajun Pharmaceutical Group is the healthcare-focused corporate investment entity within China Huajun Group Limited, the parent holding company. Meng Guangbao controls both entities, with governance exercised through his role as Executive Chairman and his spouse's position as an Executive Director of the listed parent.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: